Astellas Pharma Inc (OTCPK:ALPMY)
$ 9.48 -0.2 (-2.07%) Market Cap: 17.00 Bil Enterprise Value: 20.82 Bil PE Ratio: 0 PB Ratio: 1.78 GF Score: 77/100

Q3 2021 Astellas Pharma Inc Earnings Call Transcript

Jan 29, 2021 / 07:00AM GMT
Release Date Price: $16.29 (-0.55%)
Unidentified Company Representative

Thank you very much for participating in the conference call organized by Astellas Pharma, Inc. today despite your very busy schedule today. I'm [Fuji], Head of Corporate Advocacy in relation. I'm delighted to service as emcee. We'd like to start the meeting on the FY 2020 third quarter financial results we announced at 12 noon today, Japan time.

During the meeting, please refer to the financial results documents posted on our website under IR section. Let me introduce the participants today. Corporate Executive Vice President, Chief Strategy Officer and Chief Financial Officer, Naoki Okamura. Okamura, nice to meet you. Chief Commercial Officer, Yukio Matsui. Matsui, thank you for your time. Development Project Management Head, Mike Kitagawa. Kitagawa, thank you very much for your time.

This material or presentation by representatives of the company and answer to some statements in the Q&A session include forward-looking statements based on assumptions and beliefs in light of the information currently available to management are subject to significant

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot